Mental health
Timing is everything: What AI need to learn about HRT and brain health
By Morgan Rose, CNM, WHNP-BC, and Dr Kudesia, triple board-certified in Reproductive Endocrinology & Infertility (REI), Obstetrics & Gynecology, and Lifestyle Medicine
The timing of when women start hormone replacement therapy (HRT) may matter more than we ever understood.
The “critical window” for starting HRT isn’t just relevant to brain health; timing has also been shown to shape cardiovascular outcomes.
Early analyses of the landmark WHI trial missed this nuance, including women long past menopause and obscuring benefits seen in those who begin therapy sooner.
Recent research presented at the American Neurological Association Annual Meeting found that women who began HRT within five years of menopause had a 32 per cent lower risk of developing Alzheimer’s disease.
Yet those who started HRT more than five years after menopause showed higher levels of tau proteins, a hallmark of Alzheimer’s, in their brains.
This “critical window” concept challenges the one-size-fits-all model of menopause care. It suggests that when we start HRT, it can be just as important as whether we start it.
Researchers at Mass General Brigham found similar patterns: women who began HRT near the onset of menopause did not show increased Alzheimer’s risk, while those who experienced early menopause with longer lifetime estrogen deprivation faced a higher risk overall.
Why Timing Matters
Women face roughly a 1 in 5 lifetime risk of Alzheimer’s disease, compared to 1 in 10 for men of the same age. The sharp drop in estrogen during menopause may help explain that gap.
Estrogen supports energy production, blood flow, and inflammation control in the brain functions that wane as levels decline.
The data suggest that initiating HRT earlier (around perimenopause or early menopause) may preserve some of these neuroprotective effects, while starting too late could heighten risk once neurodegenerative changes have already begun.
One meta-analysis showed that HRT begun soon after menopause reduced Alzheimer’s risk by over 40 per cent compared to non-users, while starting after age 60 doubled the risk.
These findings don’t make HRT a blanket prescription; they make it a precision intervention.
The Clinical Nuances AI Must Understand
If AI is going to support menopause care safely and intelligently, it needs to understand the reasons behind the actions.
1. Timing Is a Risk Modifier
“Time since menopause” is not just a demographic; it’s a clinical determinant.
AI systems must understand that the same therapy can carry opposite implications depending on when it’s initiated.
2. HRT Is Not Monolithic
There are multiple formulations, routes, and combinations.
For women who still have a uterus, adding progesterone helps protect the uterine lining and lowers the risk of endometrial cancer that can occur with estrogen-only therapy.
Topical estrogen, which has much lower absorption into the bloodstream, may be appropriate for perimenopausal women who are still having periods or postmenopausal women with a uterus who need targeted relief of vaginal or urinary symptoms.
For example:
-
- Estrogen-alone therapy can raise the risk of endometrial cancer and is typically not recommended for women with a uterus.
- Topical estrogen, with much lower systemic absorption, may be appropriate for perimenopausal women still having periods.
These distinctions must be explicitly encoded into AI frameworks to avoid oversimplified or unsafe recommendations.
3. Safety Requires Scope and Referral
Complex topics like HRT timing and neuroprotection should always prompt an automatic follow-up:
“Please consult a menopause specialist or clinician (such as one credentialed through the North American Menopause Society) to discuss the risks, benefits, and best options for you.”
AI logic must mirror how clinicians practice by inviting deeper discussion, not replacing it.
From Symptoms to Systems Thinking
We need to move beyond viewing menopause as a set of symptoms to manage, and instead see it as a neurological and metabolic inflection point in women’s lives.
That means:
- Bringing conversations about HRT earlier, during perimenopause, when neuroprotective benefits may still be possible.
- Designing AI systems that recognise context and chronology, not just keywords.
- Making personalised, evidence-based menopause guidance accessible to every woman by cutting through misinformation and connecting her to trusted care.
The Bigger Picture
For too long, women’s midlife health has been under-researched and under-resourced. The result is a data gap, which can quickly become a bias when encoded into AI.
If we want women’s health AI to truly care, it must be trained on data that understands the complexity of hormonal transitions, not just the vocabulary of them.
Because the difference between “now” and “five years from now” can determine whether a woman ages with clarity or confusion.
AI should know that.
And soon, it will.
Dr Kudesia is nationally recognised for her expertise in fertility awareness, lifestyle, and culinary approaches to reproductive health, and her advocacy for reproductive rights.
Insight
Scaling startups risk increasing gender gaps, study finds
Rapidly scaling startups often make rushed hiring choices that disadvantage women, a recent study has found.
The findings draw on more than 31,000 new ventures founded in Sweden between 2004 and 2018.
Researchers at the Stockholm School of Economics report that in male-led startups, scaling reduces the odds of hiring a woman by about 18 per cent, and the odds of appointing a woman to a managerial post by 22 per cent.
Mohamed Genedy is co-author and postdoctoral fellow at the House of Innovation, Stockholm School of Economics.
Genedy said: “During those moments of rapid growth, even well-intentioned leaders can fall back on familiar stereotypes when assessing who they believe is best suited for the role.”
The patterns emerge even in Sweden, regarded as a highly gender-equal national context.
Founders with human resources-related education counteract these challenges.
In ventures led by founders with HR training, the odds of hiring a woman increase by more than 30 per cent, and the odds of appointing a woman to a managerial role increase by 14 per cent for the same level of growth.
Genedy said: “When founders have experience with structured hiring practices, the gender gaps shrink, and in some cases even reverse.
“This shows that getting the basics of HR right early on really pays off.
“When things start moving fast, founders with HR knowledge are less likely to rely on biased instincts and more likely to hire from a broader talent pool.”
Prior experience in companies with established HR practices also helps, though to a lesser degree.
It raises the likelihood of hiring women as ventures scale, but does not significantly affect managerial appointments.
The study additionally shows these patterns are not driven by founder gender alone.
Even solo female-led ventures display similar tendencies when growing rapidly, though to a somewhat lesser degree.
In female-dominated industries, rapid growth increases the hiring of women for regular roles but still reduces the likelihood that women are appointed to managerial positions.
“When scaling accelerates, cognitive bias kicks in for everyone. Female founders are not immune to these patterns,” said Genedy.
Wellness
Study reveals why women more likely to develop PTSD
High brain oestrogen may raise women’s PTSD risk if severe stress strikes during high oestrogen phases, causing memory problems and stronger fear responses, new research has revealed.
The study found that exposure to several simultaneous stressors can lead to persistent memory problems, difficulty recalling events and stronger reactions to trauma reminders.
Tallie Baram is distinguished professor of paediatrics, anatomy and neurobiology, and neurology at UC Irvine’s School of Medicine, and led the research.
Baram said: “High oestrogen is essential for learning, memory and overall brain health.
“But when severe stress hits, the same mechanisms that normally help the brain adapt can backfire, locking in long-lasting memory problems.”
Oestrogen, which usually supports learning and memory, can increase vulnerability when levels are high in the hippocampus, a brain region central to memory formation and retrieval.
Researchers reported that female mice stressed during cycle phases with high oestrogen developed enduring memory loss and heightened fear of reminders, while lower levels were protective. Males, who also have high hippocampal oestrogen, were susceptible more mildly and through different receptor pathways.
High oestrogen loosens the packaging of DNA in brain cells, known as permissive chromatin.
This normally helps learning, but under extreme stress it can allow harmful, lasting changes in memory circuits.
Memory problems were driven by different oestrogen receptors in men and women, alpha in men and beta in women.
Blocking the relevant receptor prevented stress-related memory issues even when oestrogen stayed high. Vulnerability depended on hormone levels at the time of stress, not afterwards.
Co-author Elizabeth Heller is associate professor of pharmacology at the University of Pennsylvania Perelman School of Medicine.
She said: “A lot of what determines vulnerability is the state your brain is already in.
“If a traumatic event hits during a period when oestrogen is already unusually high, the biology can amplify the impact in lasting ways.
“This study shows that a state of high oestrogen in a specific brain region promotes vulnerability to stress in both male and female subjects.”
Mental health
Wysa awarded £5.3m to address girls’ mental health in rural India
Wysa has secured £5.3m to adapt a digital mental health programme for adolescent girls in rural India.
The funding comes from Wellcome and will support a scale-up study to tailor a clinically validated digital intervention for girls facing limited autonomy, restricted access to technology, lower literacy, stigma and family gatekeeping.
Digital interventions are app-based programmes that deliver guided tools to manage anxiety and low mood, and are tested to show clinical benefit.
The study will map cultural and practical barriers to access, adapt Wysa’s content and delivery to those realities, and then test effectiveness in real-world low-to-middle-income settings.
Wysa is a global platform that combines artificial intelligence and human support to provide psychological wellbeing services.
It is used by more than seven million users across 105 countries and works with healthcare providers, employers and governments including the UK’s NHS, the Ministry of Health in Singapore, and programmes in India.
“This funding allows us to go far beyond simple translation,” said Chaitali Sinha, chief clinical and research and development officer at Wysa and the study’s principal investigator.
“By working closely with academic and community partners, we aim to co-design a digital intervention that is not only clinically effective, but genuinely usable and relevant for adolescent girls living in rural India.”
India has more than 253 million adolescents, the largest such population globally.
Around half of mental health conditions begin before age 14, and suicide is among the leading causes of death for young people.
The study team includes Aparna Joshi from Tata Institute of Social Sciences, Ceire Costelloe and Patrick Kierkegaard from Imperial College London, Dhirendra Pratap Singh from Milaan Foundation, and Becky Inkster from the University of Cambridge.
Miranda Wolpert is director of mental health at Wellcome.
She said: “We are delighted to support Wysa in their work to adapt and scale up this evidence-based digital intervention to address anxiety and depression in adolescent girls across rural India.
“This funding was awarded as part of our call to find the best ways to develop and scale digital innovations for early intervention.”
-
Features4 weeks agoWomen’s health enters a new era – the trends shaping femtech in 2026
-
Insight3 weeks agoDesigner perfumes recalled over banned chemical posing fertility risk
-
Insight4 weeks agoBest menopause apps and products for 2026
-
Fertility1 week agoParents sue IVF clinic after delivering someone else’s baby
-
Insight2 weeks agoWomen’s health could unlock US$100bn by 2030
-
Insight4 weeks agoHigher maternal blood pressure increases risk of pregnancy complications, study finds
-
Hormonal health4 weeks agoXella Health closes US$3.7 million in pre-seed financing
-
Insight4 weeks agoInside the first wave of speakers confirmed for Women’s Health Week USA 2026





